| Literature DB >> 27629830 |
Yi Liu1, Ledan Wang2, Fang Wang3, Changzhong Li1.
Abstract
BACKGROUND Fine particulate matter with aerodynamic diameters smaller than 2.5 μm (PM2.5) has been reported to cause adverse effects on human health. Evidence has shown the association between PM2.5 exposure and adverse perinatal outcomes, and the most common method is epidemiological investigation. We wished to investigate the impact of PM2.5 on placenta and prenatal outcomes and its related mechanisms in a rat model. MATERIAL AND METHODS Pregnant rats were exposed to a low PM2.5 dose (15 mg/kg) with intratracheal instillation at pregnant day 10 and day 18, while the controls received an equivalent volume normal saline. All rats received cesarean section 24 h after the last intratracheal instillation and were sacrificed with anesthesia. Blood routine tests (BRT) and interleukin-6 (IL-6) were detected for analyzing inflammation and blood coagulation. Placenta tissue sections underwent pathologic examination, and the levels of homogenate glutathione peroxidase (GSH-Px) and methane dicarboxylic aldehyde (MDA) were determined for oxidative stress estimation. RESULTS Increased absorbed blastocysts, and lower maternal weight gain and fetal weight were found in the PM2.5 exposure group compared to controls (p<0.05). Exposure to PM2.5 caused a significant increase of blood mononuclear cells (PBMC), platelets, and IL-6 levels (P<0.01). There were no differences in GSH-Px and MDA of placenta homogenate between the 2 groups (P>0.05). Placenta pathological examination demonstrated thrombus and chorioamnionitis in the PM2.5 exposure group. CONCLUSIONS PM2.5 exposure can result in placental pathological changes and adverse perinatal outcomes. The placental inflammation and hypercoagulability with vascular thrombosis may play important roles in placental impairment, but oxidative stress appears to be less important.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27629830 PMCID: PMC5036383 DOI: 10.12659/msm.897808
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Maternal-fetal-placenta weight (in grams, mean ±SEM) and the number of absorbed blastocyst in test group and control.
| Group | n | Maternal weight | Fetal weight | Fetus | Absorbed blastocyst | Placenta weight | |
|---|---|---|---|---|---|---|---|
| Day 1 | Day19 | ||||||
| Control | 9 | 288.22±20.27 | 368.89±34.01 | 4.08±1.10 | 109 | 6 | 0.66±0.10 |
| PM2.5 | 8 | 274.90±10.18 | 313.63±15.23 | 3.11±1.54 | 80 | 17 | 0.65±0.08 |
P<0.05 in PM2.5 exposure group compared with controls.
Figure 1Systemic inflammation, blood platelet count, and placenta oxidative stress with exposure to PM2.5. The peripheral blood mononuclear cells (PBMC) (A), platelet (B), and interleukin-6 (IL-6) (C) were higher in the test group compared to the control group (* p<0.01), but red blood cell count (D) was not. The glutathione peroxidase (GSH-Px) (E) and malondialdehyde (MDA) (F) of placenta homogenate were not significantly different between the 2 groups.
Figure 2Hematoxylin and eosin (HE) staining of placental tissue. (A, B) Non-exposed placental tissue did not shown abnormal pathological changes; (C–H) Placental tissues from PM2.5 exposure rats were described by: (C, D) placental infiltration of neutrophilic granulocytes involving amniotic membrane (E) thrombus (black triangle), (F) focal fibrinoid (black arrow), and (G) amnion with flat papillae and desquamated epithelial cells [=200×]. (H) Syncytiotrophoblast nodule (white arrow) observed from exposed placenta [=400×].